Orrin Hatch

If you shudder, colleagues, at these tax-avoidance schemes; if you really get angry about matters like the double Irish with a Dutch sandwich; if you want to crack down on it, you have to be for comprehensive tax reform.

I just hope that we can figure out a way, on a bipartisan basis, to fix this.

Senator Schumer and I do not agree on everything, to say the least, but we did come up with an agreement on this issue.

In Pakistan the government consistently fails to protect its own citizens from religiously motivated violence, and the courts exploit repressive anti-blasphemy laws to prosecute religious minorities. Egypt's courts convict and imprison…

I rise to speak once again on the topic of religious liberty. This is the sixth in a series of addresses I have given on this critical subject. In my previous remarks, I have discussed why religious liberty matters and why it deserves…

FDA's proposal to regulate LDTs is a significant change that would impose considerable new burdens on regulated parties.

If we reduce that data exclusivity time, especially with regard to bio, you're talking about having to charge a lot more...

The average cost, according to what I've been told, for a pharmaceutical drug is about a billion dollars...

I'm very concerned about data exclusivity.

While these arrangements are not always problematic, we are seeing more and more of these physician-salespeople using the very devices they sell in the surgeries and procedures they perform.

The proliferation of PODs and the lack of guidance as to how these arrangements square with existing Federal law.

Transparency might not prevent every unnecessary surgery, but it's a good place to start.

I rise today to introduce the Stem Cell Therapeutic and Research Reauthorization Act of 2015. I am glad to have Senators Reed, Burr, and Franken joining me as sponsors of this bipartisan bill that will reauthorize critical, innovative, and…

Today, we are here to explore the various issues surrounding the growth and prevalence of Physician-Owned Distributors, or PODs.

Simply put, PODs are medical device businesses in which a physician is both an investor and a distributor--essentially a salesperson--of either the devices or some of the components.

Ranking Member Wyden and I will be making a formal referral to the HHS Office of Inspector General and the Department of Justice on at least one case we feel deserves review for potential criminal action.

Senator Hatch and I will be referring information about this allegation and about possible Sunshine Act violations to the Inspector General.

I hope that today's hearing will be another important step in our ongoing efforts to provide appropriate oversight and enforcement on this issue.

The patient has a right to know, and then, of course, taxpayers, because you have public payers, the people of this country, through the Medicare program.

Do you believe, as prior commissioners have--every one has told me this--that the Dietary Supplement Health and Education Act, DSHEA, provides adequate authority to regulate the dietary supplement industry and protect consumers from unsafe…

We look forward to working with the Senate Finance Committee and the Subcommittee on Health in the coming months to help eliminate Medicare abuse and save the health system and taxpayers billions of dollars.

I'm very pleased to be able to support your nomination. I'm very impressed with what you've been able to do...

There is really an urgent need for more transparency.

If we don't allow enough data exclusivity time, we're not going to develop these therapies, especially in bio, because bio is one of four or five places, four or five techniques, where we can actually find treatments and cures.

We believe these findings will say quite a bit about the lack of accountability for these types of business relationships or arrangements.